with deep learning Mikhail Ignatov, Applied Mathematics and - - PowerPoint PPT Presentation

with deep learning
SMART_READER_LITE
LIVE PREVIEW

with deep learning Mikhail Ignatov, Applied Mathematics and - - PowerPoint PPT Presentation

Designing cancer vaccines with deep learning Mikhail Ignatov, Applied Mathematics and Statistics PhD candidate Why doesnt the immune system treat cancer? 1) Tumor microenvironment suppresses activity of immune cells 2) Tumor cells are


slide-1
SLIDE 1

Designing cancer vaccines with deep learning

Mikhail Ignatov, Applied Mathematics and Statistics PhD candidate

slide-2
SLIDE 2

Why doesn’t the immune system treat cancer?

1) Tumor microenvironment suppresses activity of immune cells 2) Tumor cells are very similar to healthy cells

We can force the immune system to target tumor cells using cancer immunotherapy

slide-3
SLIDE 3

How to target tumors?

1) Proteins in a cell are sliced into small pieces - peptides

slide-4
SLIDE 4

How to target tumors?

1) Proteins in a cell are sliced into small pieces - peptides 1) Peptides are loaded onto MHC molecules

slide-5
SLIDE 5

How to target tumors?

1) Proteins in a cell are sliced into small pieces - peptides 1) Peptides are loaded onto MHC molecules 1) MHC transport peptides to cell membrane and expose them to T-cells

slide-6
SLIDE 6

How to target tumors?

Peptide recognition

1) Proteins in a cell are sliced into small pieces - peptides 1) Peptides are loaded onto MHC molecules 1) MHC transport peptides to cell membrane and expose them to T-cells 1) Upon recognition of the peptides T-cell can destroy the antigen presenting cell

slide-7
SLIDE 7

How to target tumors?

Peptide recognition

1) Proteins in a cell are sliced into small pieces - peptides 1) Peptides are loaded onto MHC molecules 1) MHC transport peptides to cell membrane and expose them to T-cells 1) Upon recognition of the peptides T-cell can destroy the antigen presenting cell

If we know, which tumor derived peptides bind to MHC, it is possible to develop tumor-specific T-cells. But ...

slide-8
SLIDE 8

The problem

There are millions of different peptides in the cell. How to predict, which of them bind to MHC and become presented to the immune system?

slide-9
SLIDE 9

The problem

There are millions of different peptides in the cell. How to predict, which of them bind to MHC and become presented to the immune system?

Using Machine Learning

slide-10
SLIDE 10

Convolutional Neural Nets for binding prediction

MHC Peptide

slide-11
SLIDE 11

Convolutional Neural Nets for binding prediction

MHC Peptide

Transform 3D model to an image

slide-12
SLIDE 12

Convolutional Neural Nets for binding prediction

MHC Peptide

Transform 3D model to an image Train the CNN to capture complicated interaction patterns

slide-13
SLIDE 13

Convolutional Neural Nets for binding prediction

MHC Peptide

Transform 3D model to an image Train the CNN to capture complicated interaction patterns Estimate binding probability

slide-14
SLIDE 14

Convolutional Neural Nets for binding prediction

Why CNNs?

1) CNNs are highly relevant for image recognition tasks 1) A large number of frameworks exists for implementing CNNs, because of their high popularity 1) All the peptide-MHC interactions are highly similar in orientation, terminis are fixed 1) Sufficient data for training: ~400000 (non)interacting pairs 1) All current prediction tools rely solely on sequence data, without taking structural information into account. This results in very poor predictions for less frequent MHC variants and as a consequence in ineffective treatment

slide-15
SLIDE 15

How to create good quality models?

Most of the training data exists only in sequence form We need to able to properly model peptide-MHC interaction ATFGHARFT

slide-16
SLIDE 16

Model ranking using SVM

Modeling protocol: 1) Randomly sample multiple peptide conformations in MHC binding site 2) Minimize molecular mechanics energy function of each model 3) Sort models by similarity to the real conformation (RMSD) 4) Compute a large number of chemical features for each model 5) Train energy function specific for peptide-MHC interaction using SVM

slide-17
SLIDE 17

Pipeline

1) Model MHC-peptide interaction using SVM-based energy function 2) Predict binding score of the created model

slide-18
SLIDE 18

Timeline

1st year: Docking protocol design steps

1. Set up the testing framework for development of energy function (currently in development) 2. Train a number of SVM models using different feature sets (Rosetta energy terms) 3. Select the best SVM model for peptide-MHC docking

CNN design steps

1. Prepare the data, create MHC-peptide models, choose training and testing sets 2. Train and test multiple CNNs with different architectures, pick the best one 3. Test the resulting CNN model on external datasets 2nd year: Study the possibility of adding patient’s T-cell repertoire. Learn to model T-cell interactions with peptide-MHC complex and introduce it into the prediction pipeline

slide-19
SLIDE 19

Thank you for attention